Ubiquitin And Proteasome Pathways
18 researchers across 6 institutions
Research in ubiquitin and proteasome pathways investigates the fundamental cellular processes that regulate protein stability and turnover. This field examines how the ubiquitin-proteasome system controls protein degradation, a critical mechanism for maintaining cellular homeostasis, responding to stress, and driving developmental processes. Investigations explore the molecular machinery involved, including ubiquitin ligases, deubiquitinating enzymes, and the proteasome itself. Researchers utilize a range of techniques, from structural biology and biophysics to cell biology and genetic manipulation, to understand how these pathways are implicated in diverse biological functions and disease states. Specific areas of focus include the role of protein degradation in cancer, neurodegenerative disorders, immune responses, and viral infections.
This research has direct relevance to Arkansas's public health priorities, particularly in understanding and developing treatments for diseases prevalent in the state, such as cancer and age-related neurological conditions. Furthermore, insights into protein degradation mechanisms can inform the development of new pharmaceuticals and therapeutic strategies, potentially supporting the state's growing biopharmaceutical sector. Understanding the toxicological effects of environmental agents on these cellular pathways, a focus at the National Center for Toxicological Research, also holds significance for public health and environmental safety across Arkansas.
The study of ubiquitin and proteasome pathways is inherently interdisciplinary, drawing upon expertise in protein structure and dynamics, molecular biology, and disease mechanisms. This work connects with research in metabolism, signaling, and pharmacological effects. Across Arkansas, this field involves a broad collaboration among researchers at multiple institutions, fostering a comprehensive approach to understanding these vital cellular processes and their implications for health and disease.
Top Researchers
| Name | Institution | h-index | Citations | Career Stage | Badges |
|---|---|---|---|---|---|
| Cam Patterson | UAMS | 94 | 42,856 | High Impact | |
| Edward T.H. Yeh | UAMS | 87 | 29,010 | High Impact | |
| Robert J. Shmookler Reis | UAMS | 44 | 5,769 | Grant PI High Impact | |
| Qiang Shi | NCTR | 35 | 10,670 | High Impact | |
| Joanna Warren | University of Central Arkansas | 24 | 2,324 | High Impact | |
| Subramaniam Ponnappan | UAMS | 11 | 580 | ||
| Sadia Hamera | UA Little Rock | 10 | 750 | ||
| Jingwei Shao | UAMS | 8 | 357 | ||
| Saikiran Raghavapuram | UAMS | 5 | 74 | ||
| Srihari Shankar | UAMS | 4 | 44 | ||
| Tanvi H Patel | UAMS | 4 | 54 | ||
| Val Irion | UAMS | 4 | 77 | ||
| Shu-Jun Dou | UAMS | 4 | 821 | ||
| Nicole Poquette | University of Arkansas | 2 | 84 | ||
| Feild Cr | UAMS | 2 | 7 | ||
| Matthew Deneke | UAMS | 0 | 0 | ||
| Suguna Sakkiah | NCTR | 0 | 0 | ||
| Sangam Chudal | Arkansas State University | 0 | 0 |
Related Research Areas
Strategic Outlook
Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW
Top US institutions in this area
- 1 Harvard University 4,010
- 2 Howard Hughes Medical Institute 2,411
- 3 National Institutes of Health 2,028
- 4 The University of Texas MD Anderson Cancer Center 2,015
- 5 Dana-Farber Cancer Institute 1,917
Cross-Institution Connections
Researchers at different institutions with overlapping expertise in Ubiquitin And Proteasome Pathways.